189 related articles for article (PubMed ID: 30862482)
1. MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis.
Zhang L; Lu P; Yan L; Yang L; Wang Y; Chen J; Dai J; Li Y; Kang Z; Bai T; Xi Y; Xu J; Sun G; Yang T
Am J Pathol; 2019 May; 189(5):1105-1120. PubMed ID: 30862482
[TBL] [Abstract][Full Text] [Related]
2. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
3. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
4. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.
Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y
World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557
[TBL] [Abstract][Full Text] [Related]
5. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
6. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
7. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
9. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
11. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
12. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
Yan X; Huang L; Liu L; Qin H; Song Z
Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
14. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of miR‑490‑3p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
Wang B; Yin M; Cheng C; Jiang H; Jiang K; Shen Z; Ye Y; Wang S
Int J Oncol; 2018 Sep; 53(3):1247-1256. PubMed ID: 29916545
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.
Lu W; Wang J; Yang G; Yu N; Huang Z; Xu H; Li J; Qiu J; Zeng X; Chen S; Li N; Liu H
Oncotarget; 2017 Feb; 8(9):15242-15251. PubMed ID: 28146425
[TBL] [Abstract][Full Text] [Related]
18. PIM3 Functions as Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer.
Qi Q; Pan Y; Han S; Liao H; Jiang Y; Shen J; Zhong L; Wang X; Chen J
Anat Rec (Hoboken); 2019 Sep; 302(9):1552-1560. PubMed ID: 30417983
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
20. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
